Charlotta Backman started as Sartar’s Head of Clinical Development

Great news for the beginning of December! Sartar has appointed Charlotta Backman as Head of Clinical Development, effective December 1st. Charlotta’s long and diverse experience in designing and conducting clinical trials brings strong expertise to the Sartar team, ensuring that the company progresses in its clinical development as planned.

“It is really great to be able to strengthen Sartar’s core team as we prepare for the clinical phase. Charlotta brings solid expertise in clinical operations particularly in first in human trials in oncology and has a deep understandsingof small biotech environment. It already feels as though Charlotta has been a part of the team for several years.” says CEO Mikael Maksimow.

Charlotta Backman comments on her new role: “Sartar’s product has the potential to make a great difference in a patient population with a high unmet medical need. The first-in-human space is very familiar to me, and I look forward to joining the team at this exciting stage of clinical development.”